Ser(203) as well as Ser(204) and Ser(207) in fifth transmembrane domain ofthe human beta(2)-adrenoceptor contributes to agonist binding and receptoractivation

Citation
T. Sato et al., Ser(203) as well as Ser(204) and Ser(207) in fifth transmembrane domain ofthe human beta(2)-adrenoceptor contributes to agonist binding and receptoractivation, BR J PHARM, 128(2), 1999, pp. 272-274
Citations number
11
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BRITISH JOURNAL OF PHARMACOLOGY
ISSN journal
00071188 → ACNP
Volume
128
Issue
2
Year of publication
1999
Pages
272 - 274
Database
ISI
SICI code
0007-1188(199909)128:2<272:SAWASA>2.0.ZU;2-6
Abstract
We examined the contribution of Ser(203) of the human b(2)-adrenoccptor (b( 2)-AR) to the interaction with isoprenaline. The affinity of (-)-isoprenali ne was reduced by substitution of an alanine for Ser(203), as well as for S er(204) and Ser(207). An (-)-isoprenaline derivative with only one hydroxyl group, at the meta-position, showed reduced affinity for wild-type b(2)-AR and S207A-b(2)-AR and even lower affinities for S203A-b(2)-AR and S204A-b( 2)-AR. By contrast, an (-)-isoprenaline derivative with only a pa, a-hydrox yl group showed reduced affinity for wild-type b(2)-AR but the serine to al anine mutations did not cause further decreases. The EC50 value for cyclic AMP generation in response to (-)-isoprenaline was increased. by about 120 fold, for each alanine-substituted b(2)-AR mutant. These results suggest th at Ser(203) of the human b(2)-AR is important for both ligand binding and r eceptor activation.